What's breaking now, across thousands of outlets.
When people stop taking antidepressants, they can feel terrible—their mood can plummet and anxiety can spike. But are these symptoms caused by withdrawal, or are they signs of a relapse?
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
The drugmaker Alkermes said a therapy called an orexin agonist for the first time showed potential to treat people with ADHD in an early-stage study.
For health plans: the real fix for rising IDR disputes starts before arbitration. See how 93% get resolved early.
Biological threat intelligence is increasingly becoming a workforce and business issue, not just a public health concern.
Real-time data, analytics and collaboration can help Medicaid programs resolve issues earlier—without sacrificing participant choice.
Intelliguard’s new interactive ROI tool helps U.S. and Canadian health systems quantify potential five-year savings across medication inventory, labor, waste, charge capture and supply-chain…
New global survey finds 71% of employees connect their reason for seeking care to workplace stress; half say better management would have resolved it. 60% say we’re overly reliant on therapy.
